Vaxart Inc.
VXRT | OTC
$0.57
+$0.04 (+6.70%)
At close: Jul 14, 2026, 3:50 PM ET
+6.70%
(1D)No price chart data available for 1D timeframe.
Rating
Key Statistics
Market Data
Market Cap $138.72M
1D Range
0.53 0.58
52W Range
0.31 0.84
Valuation (TTM)
PE 4.07
PB 1.47
EV/EBITDA 1.88
Valuation (NTM)
Forward PE N/A
Forward PEG N/A
Price Target $2.00
Cash Flow
FCF Yield 10.7%
SBC Adj. FCF Yield 5.4%
SBC Impact -49.6%
Margins
Gross Margin 100.0%
Operating Margin 14.9%
FCF Margin 5.8%
Growth (CAGR)
Revenue 3Y | 5Y 1204.0% |
125.8%
Dil EPS 3Y | 5Y 43.9% |
41.2%
FCF 3Y | 5Y 35.8% |
26.1%
Returns
ROA 20.6%
ROE 61.4%
ROIC 35.7%
Financial Health
Net Cash
$53.05M
Current Ratio 1.71
Interest Coverage 16.38
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Vaxart, Inc. operates as a biotechnology firm currently in the clinical development phase, concentrating its efforts on identifying and advancing novel oral recombinant protein vaccines. The company l...
Sector Healthcare
Industry Biotechnology
Employees 105
IPO Date Dec 11, 1981
Website vaxart.com
Fiscal Year January - December
Latest News
No news articles available yet.
Add to Watchlist
Select watchlists to add or remove VXRT